1. Carbimazole/thiamazole linked with malformations, pancreatitis

   Correspondence 02 February 2019 Pages: 1 - 1

2. OA/RA capsules pulled from Australian shelves

   News item 02 February 2019 Pages: 2 - 2

3. Risk of Fournier's gangrene with SGLT2 inhibitors

   Correspondence 02 February 2019 Pages: 3 - 3

4. Adverse events with 9-valent HPV vaccine during pregnancy

   Clinical study 02 February 2019 Pages: 4 - 4

5. Baricitinib for RA: cardiovascular disorders and VTE

   Clinical study 02 February 2019 Pages: 5 - 5

6. Implementation rates of STOPP/START recommendations

   Clinical study 02 February 2019 Pages: 6 - 6

7. Increased bleeding risk with aspirin in patients without CVD

   Review 02 February 2019 Pages: 7 - 7

8. Risk of falling with anticholinergic drugs

   Clinical study 02 February 2019 Pages: 8 - 8

9. Tamoxifen for male breast cancer: thrombotic event risk

   Clinical study 02 February 2019 Pages: 9 - 9

10. Ruellia bahiensis

    Case report 02 February 2019 Pages: 10 - 10

11. Abacavir/dolutegravir/lamivudine

    Case report 02 February 2019 Pages: 11 - 11

12. Abatacept/methotrexate

    Case report 02 February 2019 Pages: 12 - 12

13. Afatinib

    Case report 02 February 2019 Pages: 13 - 13

14. Alectinib

    Case report 02 February 2019 Pages: 14 - 14

15. Alemtuzumab

    Case report 02 February 2019 Pages: 15 - 15

16. Alteplase

    Case report 02 February 2019 Pages: 16 - 16

17. Alteplase

    Case report 02 February 2019 Pages: 17 - 17

18. Aminocaproic-acid

    Case report 02 February 2019 Pages: 18 - 18

19. Amiodarone

    Case report 02 February 2019 Pages: 19 - 19

20. Amiodarone/flecainide

    Case report 02 February 2019 Pages: 20 - 20

21. Amiodarone/rivaroxaban interaction

    Case report 02 February 2019 Pages: 21 - 21

22. Amphotericin B liposomal/posaconazole/voriconazole

    Case report 02 February 2019 Pages: 22 - 22

23. Amphotericin-b-liposomal

    Case report 02 February 2019 Pages: 23 - 23

24. Anlotinib

    Case report 02 February 2019 Pages: 24 - 24

25. Anti-CD138-CAR-transduced-T-cells/bb-2121

    Case report 02 February 2019 Pages: 25 - 25

26. Antibacterials

    Case report 02 February 2019 Pages: 26 - 26

27. Antiepileptic-drugs

    Case report 02 February 2019 Pages: 27 - 27

28. Antineoplastic

    Case report 02 February 2019 Pages: 28 - 28

29. Antineoplastics

    Case report 02 February 2019 Pages: 29 - 29

30. Antineoplastics

    Case report 02 February 2019 Pages: 30 - 30

31. Antineoplastics

    Case report 02 February 2019 Pages: 31 - 31

32. Antineoplastics

    Case report 02 February 2019 Pages: 32 - 32

33. Antineoplastics

    Case report 02 February 2019 Pages: 33 - 33

34. Antineoplastics

    Case report 02 February 2019 Pages: 34 - 34

35. Antineoplastics

    Case report 02 February 2019 Pages: 35 - 35

36. Antineoplastics

    Case report 02 February 2019 Pages: 36 - 36

37. Antineoplastics

    Case report 02 February 2019 Pages: 37 - 37

38. Antineoplastics interaction

    Case report 02 February 2019 Pages: 38 - 38

39. Antineoplastics/clarithromycin

    Case report 02 February 2019 Pages: 39 - 39

40. Antineoplastics/folinic acid

    Case report 02 February 2019 Pages: 40 - 40

41. Antipsychotics/thiamazole

    Case report 02 February 2019 Pages: 41 - 41

42. Antithymocyte-globulin/ciclosporin

    Case report 02 February 2019 Pages: 42 - 42

43. Antithymocyte-globulin/ciclosporin/quinine

    Case report 02 February 2019 Pages: 43 - 43

44. Anxiolytics/linezolid/trazodone interaction

    Case report 02 February 2019 Pages: 44 - 44

45. Apixaban/dabigatran etexilate/rivaroxaban

    Case report 02 February 2019 Pages: 45 - 45

46. Argatroban/heparin

    Case report 02 February 2019 Pages: 46 - 46

47. Aripiprazole

    Case report 02 February 2019 Pages: 47 - 47

48. Ascorbic acid

    Case report 02 February 2019 Pages: 48 - 48

49. Aspirin

    Case report 02 February 2019 Pages: 49 - 49

50. Atenolol

    Case report 02 February 2019 Pages: 50 - 50